FDA inspection
GlaxoSmithKline Biologicals: FDA inspection ending Jun 27, 2013
FDA inspection 846830 · Voluntary Action Indicated (VAI) · Dresden
Key facts
| Inspection ID | 846830 |
|---|---|
| Firm | GlaxoSmithKline Biologicals |
| FEI number | 3004835618 |
| Address | Zirkusstr. 40 |
| City | Dresden |
| Fiscal year | 2013 |
| Inspection end date | Jun 27, 2013 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccine, Allergenic, and Live Biotherapeutic Products |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data